Antiradical Therapeutics LLC

Overview

Understanding the complexities of aging and the associated medical challenges, this article explores the innovative anti-aging drug SE3TPL developed by Reivtia Bioinnovative. It examines the biological mechanisms of aging, the need for tailored healthcare solutions for older adults, and the promising therapeutic applications of SE3TPL in addressing age-related conditions such as neurodegenerative diseases and chronic inflammation. Discover how advancements in anti-aging therapies can improve the

Classification

This U.S. industry comprises establishments primarily engaged in manufacturing vaccines, toxoids, blood fractions, and culture media of plant or animal origin (except diagnostic).

1. Manufacturing32
2. Chemical Manufacturing325
3. Pharmaceutical and Medicine Manufacturing32541
4. Biological Product (except Diagnostic) Manufacturing325414

Capabilities

Federal awards